原料辞典検索/sodium-citrate/SODIUM CITRATE
Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
合成 (Synthetic)

SODIUM CITRATE

日本化粧品工業連合会 (JCIA) 表示名称: クエン酸Na
pH調整剤キレート剤(金属イオン封鎖剤)香料緩衝剤(バッファー)
結論先行 エグゼクティブ規制・安全性ファクトボックスAEO / GEO CITATION ANCHOR

化粧品における クエン酸Na (SODIUM CITRATE) のグローバル配合基準と処方特性とは?

クエン酸Na(標準 INCI: SODIUM CITRATE、CAS番号: 994-36-5)は、化粧品処方において主にpH調整剤, キレート剤(金属イオン封鎖剤), 香料として配合される原料です。日本厚労省/JCIA(規制なし)、韓国MFDS(規制なし)、欧州CosIng(規制なし)など6大法域の法定基準下で管理され、通常 0.1–0.3%(適正安定域 pH 4–8)で処方されます。

7大トラック 国別・用途別 公式全成分表示名称マトリクス

各国公的告示原典のみ収録 · 機械翻訳・任意音訳ゼロ
7-Track Official Statutory Label Names for SODIUM CITRATE
法域・規制トラック公式全成分表示名称ワンクリックコピー
① 韓国 (MFDS 化粧品標準名称)SODIUM CITRATE (KR MFDS Registered)
② 韓国旧名称履歴 (301 リダイレクト)——
③ 欧州連合 (EU CosIng EC 1223/2009)SODIUM CITRATE
④ 米国一般化粧品 (US PCPC / MoCRA INCI)SODIUM CITRATE
⑤ 米国 FDA OTC モノグラフ有効成分名— (米国 OTC 対象外 / 一般化粧品原料)—
⑥ 中国 (NMPA IECIC 標準中国語名称)柠檬酸钠
⑦ 日本化粧品表示名称 / 医薬部外品外原規名称 (JCIA / MHLW)クエン酸Na · [QD: クエン酸ナトリウム]

Layer 1 — 6大法域 法定配合上限および規制ステータス

Layer 1 Statutory Regulatory Limits Across 6 Regions for SODIUM CITRATE
法域規制ステータス配合上限制限条件および一次法源出典
韓国 (MFDS)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
欧州 (EU)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
米国 (FDA)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
中国 (NMPA)配合可能GMPIECIC Entry #4856
日本 (MHLW)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
ASEAN (ACD)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
⚠️ 参考用案内 (免責事項): 本辞典の成分名・規制上限・処方ガイドは研究開発の参考用です。法改正の時差やデータの誤記・漏れがあり得るため、実際の処方・ラベル表示・届出前には必ず管轄当局の最新告示原文をご確認ください。本情報の利用により生じた問題について運営主体は法的責任を負いません。
Interactive Quartile Box-Plot (Min–Q1–Median–Q3–Max)

Layer 3 Formulation Concentration Box-Plot vs. Statutory Limit

Emulsion / Creamn=6
Min 0.1% · Q1 0.15% · Median 0.15% · Q3 0.2625% · Max 0.3%
Emulsion / Cream — Emulsion cream & lotion structural / conditioning agent
Verified Source: Global Starter Formulation Library Statistical Distribution (n=6, EVONIK 5 · GRANT 1) (cir_safety) · EVONIK 5 · GRANT 1
Typical Median: 0.15%

Layer 3 — 剤形別通常配合濃度 (四分位数 n≥5) & 物理化学・相溶性ガイド

Layer 3 Formulation Concentration Quartiles by Product Category for SODIUM CITRATE
剤形グループMin – Q1 – Median – Q3 – Max (%)処方役割・作用機序Source ID
剤形群 B — 乳液・エマルジョン・クリーム0.1% · 0.15% · 0.15% · 0.2625% · 0.3%Emulsion cream & lotion structural / conditioning agentGlobal Starter Formulation Library Statistical Distribution (n=6, EVONIK 5 · GRANT 1)
Cutaneous Permeation Science (500 Dalton Rule)MW: Macro/Complex · LogP: N/A

Stratum Corneum Penetration Depth & Bio-Spicule Transdermal Delivery

Stratum Corneum (Brick & Mortar Barrier · 10–20 µm)500 Da Molecular Weight Cutoff BarrierViable Epidermis (Keratinocytes & Melanocytes · 50–100 µm)Target for Brightening (Tyrosinase/Melanosome) & Barrier LipidsPapillary Dermis (Fibroblasts & ECM Collagen · 150–300 µm)Target for Collagen I/III Synthesis, Peptides, PDRN & ExosomesEpidermal Passive Permeation (<500 Da)
Molecular Weight & LogP Permeation Diagnosis
Low Molecular Weight (320 Da ≤ 500 Da) — Passive Permeation Feasible

Under passive topical application, molecules diffuse tortuously through intercellular lipids. Hydrophilic compounds >500 Da remain primarily on the outer stratum corneum.

Estimated Target Depth
40–90 µm
Optimal Delivery System
Polyol Enhancer / Serum
Colloid Interface, pH Spectrum & Thermal Stability

pH Stability Window (0–14), Thermal Limit & HLB Colloidal Phase Behavior

Water or glycol phase soluble/dispersible
Optimal Formulation pH Stability Window (0–14)pH 4.0 – 8.0
0245.5791114

Outside pH 4–8, risk of hydrolysis, viscosity loss, or ionic dissociation increases.

Maximum Thermal Processing Limit (°C)≤ 50°C
25°C45°C60°C75°C85°C100°C

Thermally stable up to 50°C during standard emulsification.

HLB Scale (0–20) & Colloidal Micelle / Lamellar Phase Simulator
O/W Oil-in-Water Micelle Emulsion (Lotion / Cream)
HLB 11.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)O/W Droplet
Biochemical Signaling & Mechanism Pathway

Cellular & Molecular Target Mechanism Flow

1. Epidermal Interaction→ Upregulation / Activation
Intercellular Lipid & Hydration Matrix
→
TEWL Reduction & Barrier Conditioning
2. Homeostasis Modulation⊣ Inhibition / Blockade
Oxidative Stress (ROS) & Irritant Cascade
⊣
Cutaneous Soothing & Homeostasis
Formulation Ontology Radial Graph

Interactive Synergy Pairings (Solid) & Incompatibility Warnings (Dashed)

+ GLYCERIN+ CAPRYLIC/CAPRIC TR…+ TOCOPHEROL✕ Verify phase compati…SODIUM CITRATE
Interactive Node Guide

Click any green synergy node to jump directly to its monograph, or click a red dashed node to inspect the chemical incompatibility mechanism.

代表商品名参考 (商標法第90条第1項第2号 記述的表示)
SODIUM CITRATE

商品名は研究者がグレードを識別するための参考表記であり、各商標権は原メーカーに帰属します。

学術・毒性・処方統合モノグラフ

Tier 1 Synthesis

本原料に紐づく NIH PubMed 査読付き論文アブストラクトおよび公的毒性評価報告書のみに基づいて作成された学術要約です。

■ [1. Chemical Identity & International Labeling Nomenclature] - INCI Name: SODIUM CITRATE | CAS No.: 994-36-5 | EC No.: 200-675-3 - Origin: SYNTHETIC | Functions: pH, , , - Physicochemical Profile: Formula | MW /(Polymer/Complex) | / | Ionic Nature: non-ionic | CosIng/MFDS - Official Regional Label Names: US [SODIUM CITRATE] · EU [SODIUM CITRATE] · CN [柠檬酸钠] · JP [クエン酸Na] · JP Quasi-Drug [クエン酸ナトリウム] ■ [2. Dermatological Mechanism of Action & Functional Role] - SODIUM CITRATE functions primarily as pH, , , in dermatological and cosmetic formulations. Classified under origin 'synthetic', it acts within the cosmetic vehicle or stratum corneum to deliver pH, , , performance and structural formulation stability. ■ [3. Global 6-Jurisdiction Regulatory Status & Safety Limits (Layer 1 & Layer 2)] - Regional Summary: KR: NONE | EU: NONE | US: NONE | CN: ALLOWED | JP: NONE | ASEAN: NONE (CN IECIC (2025) Entry No. 4856 (柠檬酸钠)) - No specific Annex prohibition or numeric restriction across the 6 major jurisdictions (Permitted under general GMP safety assessment). - Official Safety & Historical Use Concentration (Layer 2): Quantum satis (QS) within standard cosmetic safety margins ■ [4. Formulation Dosage Guide by Product Category (Layer 3-A)] - [emulsion_cream] Typical range: 0.1 ~ 0.3% (Median 0.15%, Ref: Global Starter Formulation Library Statistical Distribution (n=6, EVONIK 5 · GRANT 1)) — Emulsion cream & lotion structural / conditioning agent ■ [5. Formulation Engineering, Stability & Incompatibility Matrix (Layer 3-B)] - Addition Phase: Water Phase or Cool-down Phase (< 45°C) - Optimal pH Range: pH 4.0 ~ 8.0 | Max Process Temp: Max 50°C | Electrolyte Tolerance: MEDIUM - Incompatibility / Caution: Verify phase compatibility under extreme pH or high electrolyte loads - Synergy Pairings: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL | Reference Trade Names: SODIUM CITRATE ■ [6. Peer-Reviewed Literature & Official Compendia Evidence] - PMID 40961341 (2025, Biomacromolecules): Rapid Template-Transferred Printing of Gelatin-Based Ionogels with Bioinspired Hierarchical Microstructures for Flexible - PMID 40808612 (2025, J Biomed Mater Res A): Fish Collagen-Based Bilayer Composite Scaffold Functionalized With Fibrin/Hydroxyapatite/Sodium Citrate for Osteochondra - PMID 40167422 (2025, ACS Appl Mater Interfaces): Exudate Management, Facile Detachment, and Immunometabolism Regulation for Wound Healing Using Breathable Dressings

関連査読付き学術論文 (NIH PubMed) (12)

Rapid Template-Transferred Printing of Gelatin-Based Ionogels with Bioinspired Hierarchical Microstructures for Flexible Tactile Sensors [PMID: 40961341 · 2025]
Qiu L, Li N, Li B, Feng L, Ji X, Chen W · Biomacromolecules (2025)

Flexible pressure sensors are pivotal for e-skin, artificial intelligence interactions, and personalized medicine. Nevertheless, integrating high sensitivity, a broad detection range, and biodegradability remains difficult. Herein, we developed a flexible piezoresistive tactile sensor comprising a gelatin/deep eutectic solvent/sodium citrate (GDS) ionogel substrate, a carbon nanotube (CNT)/gelatin sprayed hierarchical microstructure sensing layer, and a gelatin gel-based interdigitated electrode. The hierarchical microstructures and interdigital microgrooves, fabricated via template transfer printing, mimic the interlocking spinous structures of human skin, enhancing stress distribution and sensitivity. Due to the superior mechanical properties of the GDS ionogel matrix and the "interlocking effect" between the microstructures and interdigital electrode, the sensor achieves high sensitivity (6.16 kPa -1 ), broad range (up to 173 kPa), fast response (&lt;10 ms), low detection limit (10 Pa), and excellent cycling stability over 8000 cycles. Applications in human activity monitoring and human-computer interaction highlight its potential for ultraprecise sensing.

Fish Collagen-Based Bilayer Composite Scaffold Functionalized With Fibrin/Hydroxyapatite/Sodium Citrate for Osteochondral Tissue Engineering-In Vitro and In Vivo Studies [PMID: 40808612 · 2025]
Vijayalekha A, Anandasadagopan SK, Gopal T, Durai S, Anumaiya V, Pandurangan AK · J Biomed Mater Res A (2025)

Osteochondral defects (OCDs) present significant clinical challenges, necessitating scaffolds that effectively regenerate both cartilage and subchondral bone. We developed a bilayer scaffold using fish collagen extracted from Catla catla skin to overcome the limitations of conventional biomaterials, such as mammalian collagen and synthetic polymers, which often suffer from immunogenic risks, poor bioactivity, or inadequate structural integration. The scaffold is comprised of collagen/fibrin (CC/FIB) for the articular cartilage layer and collagen/sodium citrate/hydroxyapatite (CC/NAC/HAP) for the subchondral bone layer, which is cross-linked with citric acid. Physicochemical characterization confirmed scaffold integration, enhanced thermal stability, and a porous architecture. The scaffold demonstrated optimal porosity (63.12%), degradation (62.08% over 28&#x2009;days), superior swelling potential, and enhanced bio-mineralization in simulated body fluid. In&#xa0;vitro studies using MG-63 osteoblast-like cells and MC3T3-E1 cells showed high biocompatibility, increased alkaline phosphatase activity, and enhanced calcium deposition (33.73&#x2009;&#xb1;&#x2009;0.53&#x2009;&#x3bc;g/mg of protein at 21&#x2009;days). Gene expression analysis revealed upregulation of osteogenic (COL I ~23-fold, RUNX-2 ~15-fold, OCN ~8-fold) and chondrogenic (COL II ~12-fold, SOX-9 ~10-fold, ACAN ~6-fold) markers, confirming osteochondral regeneration potential. In&#xa0;vivo studies involving the implantation of 3&#x2009;mm femoral trochlear OCDs in albino Wistar rats (n&#x2009;=&#x2009;3 per group) resulted in substantial bone and cartilage regeneration, with complete defect closure by 12&#x2009;weeks. Radiographic and histological assessments at 4, 8, and 12&#x2009;weeks confirmed well-organized osteochondral repair, demonstrating superior regenerative capability compared to control groups. This study establishes the novelty of the fish collagen-based bilayer scaffold as a promising candidate for osteochondral tissue engineering, supporting effective cartilage and subchondral bone regeneration in OCD treatment.

Exudate Management, Facile Detachment, and Immunometabolism Regulation for Wound Healing Using Breathable Dressings [PMID: 40167422 · 2025]
Li M, Nie J, Li X, Ye L, Wang Z, Yang J · ACS Appl Mater Interfaces (2025)

Developing breathable dressings with multifunctional properties (such as exudate management, easy removal, and immunometabolism regulation) presents significant challenges in wound healing. This study employs the Hofmeister effect to prepare a sodium citrate-cross-linked cryogel (CA-CS) with versatile functions, including porous and loose structures, rapid shape recovery ability, superior fatigue resistance behavior, and outstanding biocompatibility capabilities. The CA-CS cryogels demonstrated strong anti-inflammatory properties by reversing the lipopolysaccharides-induced M1 macrophages and increasing M2 macrophage percentages in vitro . Additionally, these breathable CA-CS cryogels exhibited superior hemostatic activity in vivo . The easily detachable CA-CS cryogels enhanced nutrient exchange, promoted exudate absorption, regulated immune response, and induced metabolic reprogramming, thereby supporting skin regeneration and hair follicle formation in a full-thickness skin defect mouse model. We expect that these CA-CS cryogels will drive the development of next-generation dressings for effective wound regeneration in clinical practice.

Electrospun Collagen-Coated Nanofiber Membranes Functionalized with Silver Nanoparticles for Advanced Wound Healing Applications [PMID: 39997665 · 2025]
Iurilli M, Porrelli D, Turco G, Lagatolla C, Camurri Piloni A, Medagli B, Nicolin V, Papa G · Membranes (Basel) (2025)

Complex wounds pose a significant healthcare challenge due to their susceptibility to infections and delayed healing. This study focuses on developing electrospun polycaprolactone (PCL) nanofiber membranes coated with Type I collagen derived from bovine skin and functionalized with silver nanoparticles (AgNPs) to address these issues. The collagen coating enhances biocompatibility, while AgNPs synthesized through chemical reduction with sodium citrate provide broad-spectrum antimicrobial properties. The physical properties of the membranes were characterized using scanning electron microscopy (SEM) and atomic force microscopy (AFM). Results showed the formation of nanofibers without defects and the uniform distribution of AgNPs. A swelling test and contact angle measurements confirmed that the membranes provided an optimal environment for wound healing. In vitro biological assays with murine 3T3 fibroblasts revealed statistically significant ( p &#x2264; 0.05) differences in cell viability among the membranes at 24 h ( p = 0.0002) and 72 h ( p = 0.022), demonstrating the biocompatibility of collagen-coated membranes and the minimal cytotoxicity of AgNPs. Antibacterial efficacy was evaluated against Staphylococcus aureus (SA), Pseudomonas aeruginosa (PA), and Vancomycin-resistant Enterococcus (VRE), with the significant inhibition of biofilm formation observed for VRE ( p = 0.006). Overall, this novel combination of collagen-coated electrospun PCL nanofibers with AgNPs offers a promising strategy for advanced wound dressings, providing antimicrobial benefits. Future in vivo studies are warranted to further validate its clinical and regenerative potential.

Studying the Effect of Reducing Agents on the Properties of Gold Nanoparticles and Their Integration into Hyaluronic Acid Hydrogels [PMID: 39769926 · 2024]
Adamska E, Kowalska A, Wcis&#x142;o A, Zima K, Grobelna B · Molecules (2024)

Gold nanoparticles (Au NPs) are a promising target for research due to their small size and the resulting plasmonic properties, which depend, among other things, on the chosen reducer. This is important because removing excess substrate from the reaction mixture is problematic. However, Au NPs are an excellent component of various materials, enriching them with their unique features. One example is hydrogels, which provide a good, easily modifiable base for multiple applications such as cosmetics. For this purpose, various compounds, including hyaluronic acid (HA) and its derivatives, are distinguished by their high water-binding capacity and many characteristics resulting from their natural origin in organisms, including biocompatibility, biodegradability, and tissue regeneration. In this work Au NPs were synthesized using a green chemistry method, either by using onion extract as a reductant or chemically reducing them with sodium citrate. A complete characterization of the nanoparticles was carried out using the following methods: Fourier-Transform Infrared Spectroscopy (FT-IR), Electrophoretic (ELS), and Dynamic Light Scattering (DLS) as well as Transmission Electron Microscope (TEM) and Scanning Electron Microscope (SEM). Their antioxidant activity was also tested using the 2,2-diphenyl-1-picrylhydrazyl radical (DPPH). The results showed that the synthesized nanoparticles enrich the hydrogels with antioxidant properties and new surface properties (depending on the reducing agent, they can be more hydrophilic or hydrophobic). Preliminary observations indicated low cytotoxicity of the nanomaterials in both liquid form and as a hydrogel component, as well as their lack of penetration through pig skin. The cosmetic properties of hydrogel masks were also confirmed, such as increasing skin hydration.

Construction of high strength PVA/cellulose conductive hydrogels based on sodium citrate/aluminium chloride dual ions regulation [PMID: 39542291 · 2024]
Han M, Yao Z, Ye Q, Wang Y, Zhou D, Yang W · Int J Biol Macromol (2024)

Hydrogels used for flexible sensing usually require a good balance between mechanical strength and conductivity. In this study, polyvinyl alcohol/carboxymethyl cellulose/cellulose nanofibers (PVA/CMC/CNF) hydrogels with multi-hierarchical structures were firstly prepared by adjusting the CNF content. Then, PVA/CMC/CNF-xM with excellent mechanical properties and conductivity were prepared by cyclic freezing-thawing and sodium citrate/aluminium chloride (Na 3 Cit/AlCl 3 ) dual ions salt equilibrium methods. Results showed that at an ion concentration of 3&#xa0;mol/L, PVA/CMC/CNF-3&#xa0;M hydrogel exhibited a tensile strength, elongation at break and conductivity of 3.41&#xa0;MPa, 1271&#xa0;% and 0.35&#xa0;S/m, respectively. The structural evolution of PVA/CMC/CNF-xM conductive hydrogels were studied, and the results indicated that Cit 3- formed numerous intermolecular hydrogen bonds, while Al 3+ could strongly coordinate with carboxyl and hydroxyl groups between the polysaccharide chains. Meanwhile, PVA/CMC/CNF-3&#xa0;M possessed a low strain detection limit of 1&#xa0;%, making it not only can be used for human motion monitoring, but also information encoding and transmission. This work may provide a facile approach for preparing high-strength and conductive hydrogels, which can be applied in flexible wearable electronic devices and information transmission.

Original research a real-world study of adverse events of nafamostat mesylate and sodium citrate based on the world health organization-VigiAccess database [PMID: 42244882 · 2026]
Xu M, Wang Z, Yu B · Front Pharmacol (2026)

While nafamostat mesylate (NM) and sodium citrate serve as commonly used extracorporeal anticoagulants in clinical practice, the characteristics and potential risks of their adverse events (AEs) need to be systematically evaluated. This study comparatively analyzed the reporting characteristics of the AEs of the above-mentioned two drugs based on the World Health Organization Adverse Drug Reaction Reporting Database (WHO-VigiAccess), to identify their safety signals and provide evidence-based guidance for optimizing their clinical uses. Mining of the global AE reporting data of NM and sodium citrate was conducted using the WHO-VigiAccess database, with the data collected until 29 December 2024. Statistical analysis was performed using the Reporting Odds Ratio (ROR), the Proportional Reporting Ratio (PRR), the Bayesian Confidence Propagation Neural Network (BCPNN), and the Empirical Bayes Geometric Mean (EBGM). The signal strengths of the AEs of the two drugs at the system organ class and preferred term levels were systematically evaluated in combination with the standardized coding MedDRA. This study included 1,572 NM-related reports (59 AEs) and 485 sodium citrate-related reports (102 AEs). NM AEs were mainly concentrated in immune system diseases (23.80%), skin and subcutaneous tissue diseases (16.25%), and gastrointestinal diseases (10.10%), with strong disproportionality signals observed for thrombosis in devices (n = 18, ROR = 264.71), shock (n = 119, ROR = 186.27) and anaphylactoid shock (n = 4, ROR = 143.45). In contrast, sodium citrate-related AEs primarily included systemic diseases with various reactions at the administration site (15.75%) and gastrointestinal disorders (11.63%). The reporting proportion of mortality for sodium citrate (2.83%) was higher than that for NM, although this finding may be influenced by reporting bias and confounding by indication. In addition, this study detected signals not described in the instructions, such as citrate toxicity (ROR = 6,740.61) and spinal muscular atrophy (ROR = 665.94). Both drugs shared several high-incidence AEs, including pruritus, vomiting and dyspnea, but there are significant differences in gender, age and geographical distribution. The use of NM was associated with a strong disproportionality signal for severe immune-related AEs, such as anaphylactic shock, and requires strengthened monitoring. The metabolic complications of sodium citrate and its exposure risks during pregnancy require targeted optimization of medication strategies. Real-world data suggested that both drugs may cause AEs that were not mentioned in the instructions, so risk management needs to be improved through dynamic pharmacological vigilance. This study provided important references for individualized selection and safety management of anticoagulation regimens for patients requiring hemodialysis.

A Multifunctional Shape-Adaptive Bilayer Hydrogel for Acute Hemostasis, Wound Repair, and Insect Bite Defense [PMID: 42042185 · 2026]
He R, Yan W, Cao Q, Zhang C, Ye Y, Chen Y, Wu S, Han F, Luo S · Gels (2026)

Fieldwork carries a high risk of irregular, non-compressible traumatic wounds, which often initiate a vicious cycle of "traumatic bleeding-insect bite-secondary infection". Conventional dressings cannot combine rapid hemostasis with physical protection against venomous insects, creating an urgent demand for multifunctional field trauma dressings. To solve this problem, this study developed a shape-adaptive bilayer hydrogel that concurrently provides rapid hemostasis, promotes wound repair, and acts as a robust physical barrier. The hydrogel adopts a layered design: the bottom layer (PPTY) achieves autogelation within 3 s upon blood contact, while the top armor protective layer (AP) withstands pressures up to 942 kPa. By incorporating chitosan and sodium citrate into the AP precursor solution, the hydrogel achieved in situ formation within 50 s and developed a stable self-renewing armor layer. The tightly bonded bilayer showed complementary functions. In rat models of femoral artery puncture and tail vein bleeding, PPTY-AP hydrogel significantly reduced blood loss and shortened hemostasis time. Moreover, the hydrogel demonstrated excellent tissue adhesion and moisture retention capacity, promoting full-thickness skin wound healing. This multifunctional, rapidly deployable hydrogel presents a promising solution for field trauma management and offers a new design paradigm for advanced wound dressings.

Biodegradable sodium citrate-treated hyaluronic acid microspheres for genicular artery embolization [PMID: 41506309 · 2026]
Dowling KI, Hidjir T, Zhang L, Carlo BD, Shakeri A, Cheung KK, Young EWK, Radisic M, Moeini M, Mafeld S, Matsuura N · Acta Biomater (2026)

Genicular artery embolization (GAE) using microparticulate embolic agents has recently been shown to improve pain and function in knee osteoarthritis (OA) patients. Despite encouraging outcomes, current clinical embolics are repurposed from non-GAE applications and remain suboptimal due to non-degradability or non-spherical shape, highlighting a need for biodegradable microspherical embolics specifically designed for GAE. Here, we engineered 1,4-butanediol diglycidyl ether (BDDE)-crosslinked hyaluronic acid (HA) microspheres with properties fine-tuned for GAE using a salt treatment approach, targeting a size range of &#x223c;75-300 &#x3bc;m and degradation time of &#x223c;48 h. Sodium citrate (Cit)-treated HA (HACit) microspheres with tunable properties were fabricated via emulsion crosslinking in the presence of varying Cit concentrations (0-20% w/v, named HACit-0 to HACit-20). &gt;92% of microspheres measured between 75-300 &#xb5;m. Treatment with 10% Cit (HACit-10) reduced the average microsphere size (from 195 &#xb1; 55 &#xb5;m to 151 &#xb1; 53 &#xb5;m), decreased the swelling ratio (from 24.3 &#xb1; 3.5 to 7.4 &#xb1; 0.1), and prolonged the in vitro degradation time (from 33 &#xb1; 3 h to 56 &#xb1; 4 h) compared to untreated microspheres (HACit-0). In a microfluidic occlusion test, HACit-10 microspheres exhibited enhanced strength to stably block microchannels, while HACit-0 microspheres failed to cause obstructions. NMR analysis verified complete Cit removal after microsphere washing, leaving FDA-approved BDDE-crosslinked HA as the sole embolic material. Cytotoxicity assessments using human umbilical vein endothelial cells (HUVECs) and human dermal fibroblasts (HDFs) demonstrated cytocompatibility of HACit-10 microspheres. Collectively, HACit-10 microspheres fulfilled the proposed design criteria, representing a promising embolic agent for GAE. STATEMENT OF SIGNIFICANCE: Knee osteoarthritis (OA) is the most common joint disease, with pain being the most prominent symptom. Genicular artery embolization (GAE) provides an alternative option for a substantial subset (&#x223c;20%) of OA patients who fall into a treatment gap-those unresponsive to conservative treatments yet ineligible for total knee replacement. Hyaluronic acid (HA) microspheres are promising candidates for developing GAE-indicated embolics, as HA-based products are biocompatible, biodegradable, non-immunogenic, and FDA-approved for intra-articular injections, facilitating clinical translation. However, achieving an optimal balance of size, mechanical properties, and degradation time is challenging through crosslinker concentration adjustment alone. This study employs a recently developed salt treatment method to fabricate HA microspheres with suitable size, enhanced mechanical strength, and fine-tuned degradation kinetics, tailored for GAE.

Potential of Cricket Chitosan for Nanoparticle Development Through Ionotropic Gelation: Novel Source for Cosmeceutical Delivery Systems [PMID: 39771596 · 2024]
Inthorn J, Chomchalao P, Rithchumpon P, Juntrapirom S, Kanjanakawinkul W, Rades T, Chaiyana W · Pharmaceutics (2024)

Crickets are recognized as an alternative source of chitosan. This study aimed to assess the potential of cricket-derived chitosan as a natural source to develop chitosan nanoparticles (CNPs). Chitosan were isolated from different cricket species, including Gryllus bimaculatus , Teleogryllus mitratus , and Acheta domesticus . The isolated chitosan were characterized by their functional groups, crystallographic and thermal properties, molecular structure, morphology, water solubility, molecular weight, binding capacity, irritation potential, and cytotoxicity in comparison to commercial shrimp-based chitosan. CNPs were developed through an ionotropic gelation method, followed by the evaluation of particle size, polydispersity index (PDI), and zeta potential. The findings of this study indicate that chitosan can be successfully isolated from the three cricket species, with yields ranging from 4.35% to 5.22% w / w of the dried material. The characteristics of cricket-based chitosan were similar to those of commercial chitosan, except that the cricket-based chitosan displayed a higher crystallinity and a lower molecular weight. Additionally, CPNs were successfully produced from cricket-based chitosan using sodium citrate as a crosslinking agent. All cricket-based chitosan exhibited no irritation or cytotoxicity. Chitosan derived from A. domesticus however was found to be the most suitable to develop CPNs, as it produced the smallest particle size (522.0 &#xb1; 12.1 nm) with a comparatively narrow PDI (0.388 &#xb1; 0.026) and an acceptable positive zeta potential (34.2 &#xb1; 4.4 mV). Cricket-derived chitosan compares favorably with crustacean-derived chitosan and showed potential for a range of applications, including the use as a nanocosmeceutical delivery system in topical and cosmetic formulations.

Hyperbranched Thermosensitive Polymer-AuNP Composite Probe for Temperature Colorimetric Detection [PMID: 39598902 · 2024]
Li H, Zhou Y, Gu J, Zhong W, Li X, Liu X, Qiao Z, Liu Y · Sensors (Basel) (2024)

Temperature detection is particularly important in the medical and scientific fields. Although there are various temperature detection methods, most of them focus on broad temperature detection, and basic research in specific fields, especially the detection of subtle temperature changes (32-34 &#xb0;C) during wound infection, is still insufficient. For this purpose, a novel colorimetric temperature sensing probe is designed in this paper, which can quickly and intuitively respond to small temperature changes within a specific range through color changes. In this paper, hyperbranched polyethyleneimine (HPEI) was modified by isobutyrylation to prepare hyperbranched temperature-sensitive polymer (HPEI-IBAm). And it was combined with gold nanoparticles (AuNPs) prepared by a sodium citrate reduction method to construct an HPEI-IBAm-AuNP colorimetric probe. The probe exhibits excellent stability, even at salt concentrations of up to 12 g/L, thanks to the abundant amino functional groups and the large steric hindrance effect unique to HPEI-IBAm. In particular, the temperature detection range of the probe is precisely locked within 32-34 &#xb0;C, enabling it to respond quickly and accurately to small temperature changes of only 2 &#xb0;C. This feature is perfectly suited to the practical needs of temperature detection in infected wounds. The linear fitting coefficient of the temperature response is as high as 0.9929, ensuring the accuracy of the test results. The detection performance of the probe remained highly consistent over 10 cycles, fully proving its excellent reusability and durability. In addition, a flexible colorimetric sensor was prepared by combining the probe with polydimethylsiloxane (PDMS) film. This sensor is capable of rapidly detecting human skin temperature in real time, achieving an accuracy of 99.07% to 100.61%. It can provide a possible solution to the challenges of delayed and difficult temperature detection caused by different body parts and uneven surfaces, among others. This demonstrates its extensive practical value and potential, and it is expected to be further applied in the monitoring of wound infections.

Paintable, Fast Gelation, Highly Adhesive Hydrogels for High-fidelity Electrophysiological Monitoring Wirelessly [PMID: 39460395 · 2025]
Li L, Ye X, Ji Z, Zheng M, Lin S, Wang M, Yang J, Zhou P, Zhang Z, Wang B, Wang H, Wang Y · Small (2025)

High-fidelity wireless electrophysiological monitoring is essential for ambulatory healthcare applications. Soft solid-like hydrogels have received significant attention as epidermal electrodes because of their tissue-like mechanical properties and high biocompatibility. However, it is challenging to develop a hydrogel electrode that provides robust contact and high adhesiveness with glabrous skin and hairy scalp for high-fidelity, continuous electrophysiological signal detection. Here, a paintable, fast gelation, highly adhesive, and conductive hydrogel is engineered for high-fidelity wireless electrophysiological monitoring. The hydrogel, consisting of gelatin, gallic acid, sodium citrate, lithium chloride, glycerol, and Tris-HCl buffer solution exhibits a reversible thermal phase transition capability, which endows it with the attributes of on-skin applicability and fast in situ gelation with 15 s, thereby addressing the aforementioned limitations. The introduction of gallic acid enhances the adhesive properties of the hydrogel, facilitating secure electrode attachment to the skin or hairy scalp. To accentuate the potential applications in at-home electrophysiological health monitoring, the hydrogel electrodes are demonstrated for high-fidelity electrocardiogram recording for one hour during various daily activities, as well as in simultaneous electroencephalogram and electrocardiogram recording during a 30 min nap.

よくある質問 (FAQ)

Q1. クエン酸Na (SODIUM CITRATE) の各国公式全成分表示名称(7トラック)はどのように異なりますか?
日本化粧品工業連合会(JCIA)表示名称は 'クエン酸Na'、米国PCPC・欧州CosIng INCIは 'SODIUM CITRATE'、中国NMPA IECIC標準中国語名は '柠檬酸钠' です。
Q2. クエン酸Na (SODIUM CITRATE) のグローバル6大法域における法定配合基準 (Layer 1) は?
6大法域規制ステータス — 日本(JP): none、韓国(KR): none、欧州(EU): none、米国(US): none、中国(CN): allowed、ASEAN: none。
Q3. 処方設計における クエン酸Na (SODIUM CITRATE) の通常配合濃度 (Layer 3) と適正 pH は?
主要剤形 (emulsion_cream) において通常 0.1〜0.3%(中央値 0.15%)で配合され、適正pH範囲は 4〜8 です。
Q4. クエン酸Na (SODIUM CITRATE) の配合禁忌 (Incompatibilities) と推奨シナジー成分は?
推奨シナジーペアは GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL、配合上の注意点は Verify phase compatibility under extreme pH or high electrolyte loads です。